Recent Finacing
Recent Raise
HAYA Therapeutics develops a regulatory-genome discovery platform to identify tissue- and cell-specific long non-coding RNA targets and advance lncRNA-targeting therapeutics for cardiac fibrosis, pulmonary fibrosis, metabolic disease, and oncology.
